XML 45 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACCRUED LIABILITIES AND OTHER CURRENT LIABILITIES
9 Months Ended
Sep. 30, 2012
ACCRUED LIABILITIES AND OTHER CURRENT LIABILITIES  
ACCRUED LIABILITIES AND OTHER CURRENT LIABILITIES

6.   ACCRUED LIABILITIES AND OTHER CURRENT LIABILITIES

 

Accrued and other current liabilities consisted of the following:

 

 

 

December 31,
2011

 

September 30,
2012

 

 

 

($000s)

 

Accrued research and development.

 

3,621

 

3,335

 

Other current liabilities

 

562

 

792

 

 

 

4,183

 

4,127

 

 

During the nine months ended September 30, 2012, the Company recorded out of period reversals of pre-clinical expense accruals of $0.4 million as a decrease to accrued liabilities and other current liabilities on the consolidated balance sheets and as a decrease to research and development expenses on the consolidated statements of operations.